ASO Author Reflections: Neoadjuvant Systemic Chemotherapy in Isolated Resectable Colorectal Peritoneal Metastases: Ready for Standard of Care?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-4681
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
ASO Author Reflections: Neoadjuvant Systemic Chemotherapy in Isolated Resectable Colorectal Peritoneal Metastases: Ready for Standard of Care? ; day:12 ; month:4 ; year:2022 ; pages:1-2
Annals of surgical oncology ; (12.4.2022), 1-2
- Urheber
-
Flood, Michael P.
Ramsay, Robert
Michael, Michael
Heriot, Alexander G.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1245/s10434-022-11749-0
- URN
-
urn:nbn:de:101:1-2022062721340954713469
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Flood, Michael P.
- Ramsay, Robert
- Michael, Michael
- Heriot, Alexander G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neoadjuvant relatlimab and nivolumab in resectable melanoma
ASO Author Reflections: Peritoneal Metastases from Endometrial Cancer
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
ASO Author Reflections: Importance of Preoperative Prediction of Survival in Resectable Pancreatic Ductal Adenocarcinoma
ASO Author Reflections: Advanced Imaging Allows Better Detection of Peritoneal Metastases
A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study
Neoadjuvant relatlimab and nivolumab in resectable melanoma
ASO Author Reflections: Peritoneal Metastases from Endometrial Cancer
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
ASO Author Reflections: Importance of Preoperative Prediction of Survival in Resectable Pancreatic Ductal Adenocarcinoma
ASO Author Reflections: Advanced Imaging Allows Better Detection of Peritoneal Metastases
A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer
Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study
Neoadjuvant relatlimab and nivolumab in resectable melanoma
ASO Author Reflections: Peritoneal Metastases from Endometrial Cancer
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
ASO Author Reflections: Importance of Preoperative Prediction of Survival in Resectable Pancreatic Ductal Adenocarcinoma
ASO Author Reflections: Advanced Imaging Allows Better Detection of Peritoneal Metastases
A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer